|
![]() |
|
|
Meloxicam
drug data and news
Meloxicam drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Meloxicam | ||
| Brand Names/Synonyms | Meloxicam; Mobic | ||
| Indication | For the treatment of arthritis and osteoarthritis | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Meloxicam is an nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Prostaglandins are substances that contribute to inflammation of joints. Meloxicam inhibits prostaglandin synthetase (cylooxygenase 1 and 2) and leads to a decrease of the synthesis of prostaglandins, therefore, inflammation is reduced. | ||
| Mechanism Of Action | Anti-inflammatory effects of Meloxicam are believed to be due to inhibition of prostaglandin synthetase (cylooxygenase), leading to the inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis may be associated with the analgesic and antipyretic effects of Meloxicam. | ||
| Meloxicam News (When available) |
Vulture decline: Pressure builds to ban Diclofenac Feb 8, 2006 Rarest vultures join breeding programme Feb 28, 2006 BirdLife hopeful of diclofenac ban Feb 1, 2006 Forest dept to support drug ban to save vultures Feb 5, 2006 UK: GOVERNMENTS, NGOS AND SCIENTISTS UNITE TO SAVE VULTURES FROM ... Feb 5, 2006 Medication for endangered vultures offers hope Feb 1, 2006 Bird groups hopeful on vultures Feb 1, 2006 Ray of hope for vultures facing extinction Feb 1, 2006 Switching Drug For Livestock May Save Endangered Vultures Feb 2, 2006 Drug India Uses in Cattle Is Killing Off Vultures Feb 4, 2006 Alternative Drug Could Save Asian Vultures Jan 31, 2006 Vets Issue Vulture Death Warning Feb 6, 2006 - By Our Correspondent Feb 3, 2006 Safe pickings needed for India's vultures Feb 2, 2006 REGIONAL COOPERATION AMONG VULTURE RANGE COUNTRIES RECOMMENDED ... Feb 1, 2006 Earthweek: A Diary of a Planet Feb 7, 2006 India to ban drug blamed in vulture deaths Jan 31, 2006 Cooperation among countries suggested for saving vultures Feb 1, 2006 Phase out diclofenac to save vultures: experts Feb 1, 2006 Experts for banning use of diclofenac on vultures Feb 1, 2006 Vulture decline: Pressure builds to ban Diclofenac Feb 8, 2006 UK: GOVERNMENTS, NGOS AND SCIENTISTS UNITE TO SAVE VULTURES FROM ... Feb 5, 2006 Namibian in bid by scientists to save vultures in Asia Feb 2, 2006 Switching Drug For Livestock May Save Endangered Vultures Feb 2, 2006 BirdLife hopeful of diclofenac ban Feb 1, 2006 Forest dept to support drug ban to save vultures Feb 5, 2006 Vets Issue Vulture Death Warning Feb 6, 2006 Drug swap urged to save vultures Jan 30, 2006 Scientists Discover Remedy To Save Vultures Jan 31, 2006 Safe pickings needed for India's vultures Feb 2, 2006 Earthweek: A Diary of a Planet Feb 7, 2006 Scientists formulate Indian vulture rescue plan Jan 31, 2006 Cattle drug blamed as India's vultures near extinction Jan 31, 2006 Bird groups hopeful on vultures Feb 1, 2006 Ray of Hope for Vultures Facing Extinction Jan 31, 2006 New drug offers vulture lifeline Jan 31, 2006 Vultures driven towards extinction by painkiller Jan 30, 2006 Alternative drug could save vultures Jan 30, 2006 Drug India Uses in Cattle Is Killing Off Vultures Feb 4, 2006 Cooperation among countries suggested for saving vultures Feb 1, 2006 Experts for banning use of diclofenac on vultures Feb 1, 2006 - By Our Correspondent Feb 3, 2006 REGIONAL COOPERATION AMONG VULTURE RANGE COUNTRIES RECOMMENDED ... Feb 1, 2006 Scientists reportedly find new cattle drug Jan 30, 2006 Phase out diclofenac to save vultures: experts Feb 1, 2006 Block That Chirp: Volume Control in Crickets Jan 30, 2006 Abbott shares rise on Q4 and Guidant win Jan 26, 2006 Drug swap urged to save vultures Jan 31, 2006 Visiting Veterinarian: Arthritis pain relief for Rover Dec 7, 2005 Boehringer Ingelheim/Biolipox: a pain-free partnership Nov 16, 2005 NSAIDs too? Oct 1, 2005 What next? Oct 1, 2005 CHMP review of safety of non-selective NSAIDs, EMEA 06 Aug 2005 EMEA on the Cardiovascular Safety of Non-Selective NSAIDs Aug 2, 2005 Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite ... Jul 11, 2005 Abbott Laboratories: arthritis drugs lift profits Jul 19, 2005 Neuropathic Pain Market to Reach $3.5 Billion by 2014, Despite ... 11 Jul 2005 The Arthritis Pills With a Bigger Heart Risk Than Ibuprofen Jun 12, 2005 | ||
| Dosage Forms | TABLET | ||
| Drug_Category | Analgesics; Antineoplastic Agents; Antiemetics; Anti-inflammatory Agents; Nonsteroidal Antiinflammatory Agents (NSAIDs); Cyclooxygenase Inhibitors; Growth Inhibitors; ATC:M01AC06 | ||
| Absorption | 89% | ||
| Interactions |
-->Interactions for Meloxicam: ACE inhibitors Reports suggest that NSAIDs may diminish the antihypertensive effect of angiotensin-converting enzyme (ACE) inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors. Aspirin Concomitant administration of aspirin (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of meloxicam. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of meloxicam and aspirin is not generally recommended because of the potential for increased adverse effects. Concomitant administration of low-dose aspirin with MOBIC may result in an increased rate of GI ulceration or other complications, compared to use of MOBIC alone. MOBIC is not a substitute for aspirin for cardiovascular prophylaxis. Cholestyramine Pretreatment for four days with cholestyramine significantly increased the clearance of meloxicam by 50%. This resulted in a decrease in t1/2, from 19.2 hours to 12.5 hours, and a 35% reduction in AUC. This suggests the existence of a recirculation pathway for meloxicam in the gastrointestinal tract. The clinical relevance of this interaction has not been established. Cimetidine Concomitant administration of 200 mg cimetidine QID did not alter the single-dose pharmacokinetics of 30 mg meloxicam. Digoxin Meloxicam 15 mg once daily for 7 days did not alter the plasma concentration profile of digoxin after b-acetyldigoxin administration for 7 days at clinical doses. In vitro testing found no protein binding drug interaction between digoxin and meloxicam. Furosemide Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients. This effect has been attributed to inhibition of renal prostaglandin synthesis. Studies with furosemide agents and meloxicam have not demonstrated a reduction in natriuretic effect. Furosemide single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of meloxicam. Nevertheless, during concomitant therapy with furosemide and MOBIC, patients should be observed closely for signs of declining renal function, as well as to assure diuretic efficacy. Lithium In clinical trials, NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving lithium alone. These effects have been attributed to inhibition of renal prostaglandin synthesis by MOBIC. Patients on lithium treatment should be closely monitored when MOBIC is introduced or withdrawn. Methotrexate A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of meloxicam on the pharmacokinetics of methotrexate taken once weekly. Meloxicam did not have a significant effect on the pharmacokinetics of single doses of methotrexate. In vitro, methotrexate did not displace meloxicam from its human serum binding sites. Warfarin Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing MOBIC therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding. The effect of meloxicam on the anticoagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of warfarin that produced an INR (International Normalized Ratio) between 1.2 and 1.8. In these subjects, meloxicam did not alter warfarin pharmacokinetics and the average anticoagulant effect of warfarin as determined by prothrombin time. However, one subject showed an increase in INR from 1.5 to 2.1. Caution should be used when administering MOBIC with warfarin since patients on warfarin may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced. | ||
| Toxicity | LD50, Acute: 84 mg/kg (Rat); Oral 470 mg/kg (Mouse); Oral 320 mg/kg (Rabbit) | ||
| Organisms Affected | Humans and other mammals | ||
| Chemical IUPAC Name | 9-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-8-methyl-7,7-dioxo-7$l^{6}-thia-8-azabicyclo[4.4.0]deca-1,3,5-trien-10-one | ||
| Chemical Formula | C14H13N3O4S2 | ||
| Molecular Weight | 351.403 g/mol | ||
| Smiles String | CC1=CN=C(S1)NC(=C2C(=O)C3=CC=CC=C3S(=O)(=O)N2C)O | ||
| Melting Point | 254 °C | ||
| Water Solubility | 7.15 mg/L | ||
| State | Solid | ||
| LogP/Hphobicity | 2.801 | ||
| Isoelectric Point | 4.08 | ||
| Biotransformation | Hepatic | ||
| Half Life | 15 hours-20 hours | ||
| Protein Binding [%] | 99.40% | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.drugs.com/cons/Meloxicam.html http://www.rxlist.com/cgi/generic3/mobic.htm | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00529 | ||
| CAS Registry Number | 71125-38-7 | ||
| KEGG Compound ID | C08169 | ||
| PubChem ID | SID:10369 | ||
| PharmGKB ID | PA450353 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 2248031 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |